4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Wockhardt Limited (WOCKPHARMA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India with about 2,564 employees. Its market capitalization is roughly ₹339 billion. In the fiscal year ended 2026-03-31, WOCKPHARMA reported ₹33.2B in revenue and ₹2.1B in net income.
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹33.2B | ₹29.1B | ₹27.9B | ₹26.5B | — |
| Gross Profit | ₹21.0B | ₹17.1B | ₹15.7B | ₹14.9B | — |
| Operating Income (EBIT) | ₹4.0B | ₹1.8B | (₹530M) | (₹1.5B) | — |
| Net Income | ₹2.1B | (₹470M) | (₹4.6B) | (₹5.6B) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹9.3B | ₹9.7B | ₹8.9B | ₹7.4B | ₹7.4B | — |
| Gross Profit | ₹6.1B | ₹6.5B | ₹5.7B | ₹4.7B | ₹4.8B | — |
| Operating Income (EBIT) | ₹1.3B | ₹1.4B | ₹1.1B | ₹450M | ₹260M | — |
| Net Income | ₹1.1B | ₹1.7B | ₹590M | (₹900M) | (₹250M) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | — | — | (₹20M) |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹86.2B | ₹81.3B | ₹76.5B | ₹76.8B | — |
| Total Liabilities | ₹33.3B | ₹34.8B | ₹39.9B | ₹40.2B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive WOCKPHARMA viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms